LIMITATIONS AND DEFICIENCIES OF PHARMACO-ECONOMIC STUDIES IN THE RUSSIAN FEDERATION COMMENTS TO THE ARTICLE OF S. L. PLAVINSKIY ET AL. «PHARMACOECONOMIC ANALYSIS OF THE IMPACT ON THE BUDGET COSTS OF ADDING DEXMEDETOMIDINE (DEXDOR) INTO THE LIST OF VITAL AND ESSENTIAL DRUGS»
.
Main Author: | D. N. Protsenko |
---|---|
Format: | Article |
Language: | Russian |
Published: |
New Terra Publishing House
2017-11-01
|
Series: | Вестник анестезиологии и реаниматологии |
Online Access: | https://www.vair-journal.com/jour/article/view/61 |
Similar Items
-
PHARMACOECONOMIC ANALYSIS OF THE IMPACT ON THE BUDGET COSTS OF ADDING DEXMEDETOMIDINE (DEXDOR) INTO THE LIST OF VITAL AND ESSENTIAL DRUGS
by: S. L. Plavinskiy, et al.
Published: (2017-11-01) -
COMPARATIVE CHARACTERISTICS OF DEXDOR AND DIPRIVAN FOR SEDATION IN UROLOGICAL OPERATIONS UNDER SPINAL ANESTHESIA
by: Serhiy I. Redko, et al.
Published: (2022-03-01) -
Aligning Comments to News Articles on a Budget
by: Jumanah Alshehri, et al.
Published: (2023-01-01) -
Pharmacoeconomic evaluation of mirabegron: results of the healthcare budget impact analysis
by: A. S. Kolbin, et al.
Published: (2018-06-01) -
PHARMACOECONOMICS AS A NEW INSTRUMENT OF PHARMACEUTICAL MARKETING
by: M. V. Protsenko, et al.
Published: (2015-03-01)